CClinicalTrials.gg
Status unknownNCT00893724SAINTSUpdated Jul 20, 2011

Supplemental Adjuvants for Intracellular Nutrition and Treatment

An interventional study of Neutral pills with no medicinal effect and Inosine; Tocopherols, Tocotrienol, CoQ10 combination capsule; Niacinamide SR; Viatmin C; N-acetyl Cysteine; Complete Multivitamin with all minerals in Neovascular Age-related Macular Degeneration and Diabetic Macular Edema, sponsored by Mid-Atlantic Retina Consultations, Inc.. Status unknown at 1 site in United States. Per ClinicalTrials.gov, last updated 2011-07-20.

Sponsored by Mid-Atlantic Retina Consultations, Inc. · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jul 2011), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Sex
All
01

Study summary

Nutritional supplements have an augmentative effect on the outcomes of standard treatment of diabetic macular edema (DME) and Neovascular Age-Related Macular Degeneration (NAMD).

Read the detailed description

It has been shown that in chronic diseases, oxidative stress results from Nitric acid reacting with oxygen to form toxins that damage both somatic and mitochondrial DNA. The potential for protecting the DNA and promoting repair by using nutritional supplements will be tested by augmenting standard treatments for DME and NAMD with such supplements. The patients will be randomized to treatment group and placebo group and followed up for a year in a double masked fashion. Anatomic and visual outcomes, as well as side effects will be assessed and analyzed. If the results are promising, this pilot study can be used to design alternative (cheaper, better and longer lasting) treatments for DME, NAMD and perhaps other chronic illnesses.

02

Conditions studied

  • Neovascular Age-related Macular Degeneration
  • Diabetic Macular Edema

Keywords

  • DME
  • NAMD
  • Oxidative damage
  • Nutritional supplements/vitamins
  • DNA repair
  • NAMD/wet AMD
03

In context

Macular Degeneration

1,474 studies on the registry are indexed under Macular Degeneration; 206 are open to participants now.

This study's planned enrollment of 60 is above the median of 51 across 985 interventional studies indexed under Macular Degeneration.

Browse Macular Degeneration studies →

Lead sponsor

Mid-Atlantic Retina Consultations, Inc. is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinical Diagnosis of NAMD
  • Clinical Diagnosis of DME

Exclusion criteria

Exclusion Criteria:

  • Pregnant Women
  • Known allergy to any component used in the treatment combinations
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Placebo comparator
    P (Placebo)

    Drug: Neutral pills with no medicinal effect

  • Active comparator
    S (Supplement)

    Dietary Supplement: Inosine; Tocopherols, Tocotrienol, CoQ10 combination capsule; Niacinamide SR; Viatmin C; N-acetyl Cysteine; Complete Multivitamin with all minerals

  • Active comparator
    SM (Supplement with Minocycline)

    Drug: Inosine; Tocopherol, Tocotrienol, CoQ10 combination capsule; Niacinamide; Vitamin C; N-acetyl Cysteine; Complete Multivitamin with all minerals; Minocycline

Interventions

  • DrugNeutral pills with no medicinal effect

    Neutral pills with no medicinal effect

  • Dietary supplementInosine; Tocopherols, Tocotrienol, CoQ10 combination capsule; Niacinamide SR; Viatmin C; N-acetyl Cysteine; Complete Multivitamin with all minerals

    Inosine \[SR\] - 1\[500mg\] tablet bid Tocopherols \[200IU\], Tocotrienol \[10mg\], CoQ10 \[50mg\] - combination capsule bid Sustained Release Niacinamide - 1 \[750mg\] tablet bid Vitamin C - 1 \[1000mg\] sustained release tablet bid N-acetyl Cysteine - 1 \[600mg\] sustained release tablet qd Complete Multivitamin with all minerals - 1 tablet (sustained release) bid

  • DrugInosine; Tocopherol, Tocotrienol, CoQ10 combination capsule; Niacinamide; Vitamin C; N-acetyl Cysteine; Complete Multivitamin with all minerals; Minocycline

    Inosine \[SR\] - 1 \[500mg\] tablet bid Tocopherol \[200IU\], Tocotrienol \[10mg\], CoQ10 \[50mg\] combination capsule bid Sustained Release Niacinamide 1 \[750mg\] tablet bid Vitamin C 1 \[1000mg\] sustained release tablet bid N-acetyl Cysteine 1 \[600mg\] sustained release tablet qd Complete Multivitamin with all minerals - 1 tablet (sustained release) bid Minocycline 1 \[50mg\] tablet qd

06

What researchers measure

Primary outcomes

  1. Degree of regression (Optical Coherence Tomography)

    Time frame: Monthly

  2. Duration of regression (Optical Coherence Tomography)

    Time frame: Monthly

  3. Visual change (ETDRS)

    Time frame: Monthly

Secondary outcomes

  1. Effect on HbA1C

    Time frame: Monthly

  2. Effect on Blood pressure

    Time frame: Monthly

  3. Effect on serum uric acid

    Time frame: Monthly

07

Study locations

1 site
  • Mid-Atlantic Retina Consultations, Inc.
    Morgantown, West Virginia 26505, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 20, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00893724
Lead sponsor
Mid-Atlantic Retina Consultations, Inc.
Collaborators
West Virginia University
First posted
May 6, 2009
Start date
Jun 2009
Primary completion
Aug 2011 (estimated)
Completion
Sep 2011 (estimated)
Last update
Jul 20, 2011

Study contacts

Nabil M Jabbour, MD, FACS
principal investigator · M.A.R.C.
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion